Tag: cancer research

Setback for Bristol Myers Squibb: CheckMate -73L trial fails to meet endpoint

businessnewstoday- May 12, 2024 0

Bristol Myers Squibb (NYSE: BMY) announced that its Phase 3 CheckMate -73L trial did not achieve its primary endpoint of progression-free survival (PFS) in patients ... Read More

Innovent Biologics showcases promising preclinical data at AACR 2024

businessnewstoday- April 8, 2024 0

In a significant development for cancer research, Innovent Biologics, Inc. (HKEX: 01801), a leading biopharmaceutical company renowned for its innovative medicines in oncology, cardiovascular and ... Read More